CervoMed Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
|
|
|
||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
||
|
|
|||
(Address of principal executive offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
Item 8.01
|
Other Events
|
Item 9.01
|
Financial Statements and Exhibits
|
Exhibit No.
|
Description
|
|
99.1
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
Date: November 4, 2024
|
CervoMed Inc.
|
||
By:
|
/s/ William Elder
|
||
Name:
|
William Elder
|
||
Title:
|
Chief Financial Officer & General Counsel
|